Seeing Is Believing
Currently out of the existing stock ratings of Robert Driscoll, 169 are a BUY (89.42%), 20 are a HOLD (10.58%).
Analyst Robert Driscoll works at WEDBUSH with a stock forecast success ratio of 43.74% fulfilled within 159.18 days on average.
Robert Driscoll’s has documented 371 price targets and ratings displayed on 34 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KURA, Kura Oncology at 03-May-2024.
Analyst best performing recommendations are on ABUS (ARBUTUS BIOPHARMA CORP).
The best stock recommendation documented was for ABUS (ARBUTUS BIOPHARMA CORP) at 10/9/2018. The price target of $5 was fulfilled within 1 day with a profit of $1 (16.67%) receiving and performance score of 166.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4
$1.29 (47.60%)
4
1 days ago
1/9 (11.11%)
$1.29 (47.60%)
139
Buy
4
$1.29 (47.60%)
4
1 months ago
0/5 (0%)
$1 (33.33%)
Buy
5
$2.29 (84.50%)
6
2 months 3 days ago
0/13 (0%)
$2.21 (79.21%)
Buy
5
$2.08 (71.23%)
2 years 3 months 2 days ago
0/1 (0%)
$2.11 (73.01%)
Buy
7
2 years 10 months 6 days ago
0/4 (0%)
$3.7 (112.12%)
Which stock is Robert Driscoll is most bullish on?
Which stock is Robert Driscoll is most reserved on?
What Year was the first public recommendation made by Robert Driscoll?